Evidence map›Paper›PMID 42772747›Full record

ArticleJMIR formative research2026

Bridging Gaps in Standards for the Secondary Use of Health Data: Exploratory Standard, Tool Assessment, and Feasibility Study.

Jaleh Shoshtarian Malak, Leonie von Berlin, Irina Balaur, Rada Hussein, Philip Gribbon, Yojana Gadiya, Somayeh Abedian, Andreas Kremer, Stefan Sauermann, Francisco J Núñez-Benjumea and 7 more

Abstract read
In one paragraph

Article in JMIR formative research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jaleh Shoshtarian MalakLuxembourg Centre for Systems Biology, University of Luxembourg, Belvaux, Luxembourg.ORCID 0000-0001-6373-0578
Leonie von BerlinDiscovery Research ScreeningPort, Fraunhofer Institute for Translational Medicine and Pharmacology, Hamburg, Germany.ORCID 0000-0002-7790-0395
Irina BalaurLuxembourg Centre for Systems Biology, University of Luxembourg, Belvaux, Luxembourg.ORCID 0000-0002-3671-895X
Rada HusseinLudwig Boltzmann Institute for Digital Health and Prevention, Salzburg, Austria.ORCID 0000-0003-1257-4848
Philip GribbonDiscovery Research ScreeningPort, Fraunhofer Institute for Translational Medicine and Pharmacology, Hamburg, Germany.ORCID 0000-0001-7655-2459
Yojana GadiyaDiscovery Research ScreeningPort, Fraunhofer Institute for Translational Medicine and Pharmacology, Hamburg, Germany.ORCID 0000-0002-7683-0452
Somayeh AbedianLudwig Boltzmann Institute for Digital Health and Prevention, Salzburg, Austria.ORCID 0000-0002-6427-6941
Andreas KremerInformation Technology for Translational Medicine S.A, Esch-sur-Alzette, Luxembourg.ORCID 0000-0003-1466-0600
Stefan SauermannFaculty Life Science Engineering, FH Technikum Wien, Vienna, Austria.ORCID 0000-0003-0824-9989
Francisco J Núñez-BenjumeaInstitute of Biomedicine of Seville, IBiS/Virgen Macarena University Hospital, University of Seville, Seville, Spain.ORCID 0000-0003-0292-5122
Jens DeclerckDepartment of Public Health and Primary Care, Unit of Medical Informatics and Statistics, Ghent University, Ghent, Belgium.ORCID 0000-0002-9743-9188
Sumit MadanFraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, Germany.ORCID 0000-0001-9970-4144
Hanna Ćwiek-KupczyńskaLuxembourg Centre for Systems Biology, University of Luxembourg, Belvaux, Luxembourg.ORCID 0000-0001-9113-567X
Lukas RohatschFaculty Computer Science & Applied Mathematics, FH Technikum Wien, Vienna, Austria.ORCID 0000-0002-6168-2717
Holger FröhlichBonn-Aachen International Center for Information Technology (B-IT), University of Bonn, Bonn, Germany.ORCID 0000-0002-5328-1243
Christian MuehlendyckJohnson & Johnson Medical GmbH, Norderstedt, Germany.ORCID 0000-0001-5115-8957
Venkata P SatagopamLuxembourg Centre for Systems Biology, University of Luxembourg, Belvaux, Luxembourg.ORCID 0000-0002-6532-5880

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStandards for the secondary use of health data remain under development and do not comprehensively address specific categories of health data. Existing health data and interoperability standards are primarily designed for the primary use of health care, leaving gaps in their applicability for research, regulatory and decision-making. This research is part of the Integration of Heterogeneous Data and Evidence Towards Regulatory and Health Technology Assessment Acceptance (IDERHA) project, which creates a federated processing environment for secondary health care use cases.

objectiveThis study aims to recommend a set of standards and tools to support harmonization objectives in the secondary use of health data. The proposed standards establish a shared representation model for data providers and stakeholders, improving data adherence to findable, accessible, interoperable, and reusable (FAIR) principles and interoperability.

methodsIn this exploratory assessment and feasibility study, we performed a consensus-based evaluation of health data standards and harmonization tools across major health-data categories. State-of-the-art standards from different standard-producing organizations were evaluated based on community adoption, technical suitability, and alignment with European Health Data Space requirements. Data-harmonization tools were tested in a pilot experiment using synthetic Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM)-based data to assess the quality and feasibility of applying harmonization workflows within IDERHA. We also assessed the inherent adherence to FAIR principles of the OMOP-CDM, identifying its strengths in semantic interoperability and data reuse. Finally, we addressed the datasets handling challenges (metadata discoverability, global identifiers, access control, and licensing), which are not inherently solvable by bare data description standards, through complementary mechanisms implemented in IDERHA.

resultsWe recommend a set of standards to support the secondary use of heterogeneous health data across clinical, imaging, genomic, socioeconomic, environmental, and patient-reported outcome measure (PROM)/patient-reported experience measure (PREM) domains. This standards collection, centered on OMOP-CDM and complemented by established extensions, was paired with selected harmonization and quality-assessment tools. Feasibility testing on synthetic OMOP data confirmed the suitability of the tools for evaluating data quality, mapping accuracy, and extract, transform, and load. A lung-cancer use case demonstrated how diverse datasets can be harmonized and prepared for federated analysis. A FAIR-dataset maturity evaluation showed that integrating OMOP data into the IDERHA environment substantially improved adherence to FAIR principles-particularly in metadata completeness, interoperability, and hosting capabilities-supporting enhanced discoverability, accessibility, and reuse of standardized health data.

conclusionsBy strengthening adherence to FAIR principles, this research facilitates the broader integration of standardized health data for regulatory processes and health technology assessment applications. The proposed standards and tools provide a comprehensive overview of existing approaches, while offering solutions that can be applied to other scenarios involving the secondary use of health data.

Indexed as

Secondary Data AnalysisFeasibility StudiesHumansEHDSFAIR principleshealth data standardsOMOP-CDMsecondary use of health data

Identifiers

PMID42772747
PMCPMC13643255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.